Dxcover

Glasgow, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a liquid biopsy-based cancer diagnostics platform designed for the early detection of multiple cancer types. Dxcover is based in Glasgow, United Kingdom and was founded in 2016. Its last reported valuation was $37.8 million in Jan 2025. It has raised $21.8 million.

Last reported valuation
$37.8M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—

Who backs Dxcover?

24 investors
InvestorType
Innovate UKOther
European Innovation CouncilVenture capital
Tech Nation GroupOther
Scottish EnterpriseGrowth equity
Mercia VenturesVenture capital
Maven Capital Partners UKPE / buyout
MassBioOther
Norcliffe CapitalVenture capital
University of Strathclyde EndowmentOther
TurnerFamily office
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Dxcover investors

24 investors are on record for Dxcover, including Innovate UK, European Innovation Council, Tech Nation Group and Scottish Enterprise.

Free account
More of Dxcover with a free account
  • ·The complete investor list: 24 names
  • ·Watch Dxcover: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Dxcover. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View